scholarly journals OP88 The Hazard of Smoking for Specific Coronary Disease Phenotypes: An Electronic Health Records Study with Linked Data in 915,000 Patients

2012 ◽  
Vol 66 (Suppl 1) ◽  
pp. A34.2-A35
Author(s):  
J George ◽  
E Herrett ◽  
S Denaxas ◽  
E Rapsomaniki ◽  
A Timmis ◽  
...  
PLoS ONE ◽  
2014 ◽  
Vol 9 (11) ◽  
pp. e110900 ◽  
Author(s):  
Katherine I. Morley ◽  
Joshua Wallace ◽  
Spiros C. Denaxas ◽  
Ross J. Hunter ◽  
Riyaz S. Patel ◽  
...  

Author(s):  
Alex Hacker

IntroductionNo doubt your Electronic Health Records have been meticulously gathered, imported, validated and standardised. However, if you want to be certain that they are an accurate representation of reality, you can’t beat physically going to hospitals and cross-checking their records against yours. Our biobank did exactly this. Objectives and ApproachOur validation exercise encompassed all reported cases in our follow-up data of three key conditions: stroke, heart disease, and cancer. Key data about each hospitalisation was extracted and exported to tablet computers running custom software. Our staff then visited each hospital in this dataset seeking the corresponding medical notes, and collected additional data from those that they found including photographs of key documents. These results were then adjudicated by specialist physicians to determine the accuracy of the diagnosis, and identify disease phenotypes of interest. Finally, all these results were merged back into our follow-up data. ResultsNot only was gathering the data a huge logistical and technical challenge, integrating it back into the database presented its own difficulties. Our initial plan was to assign each sought event a status of ‘validated’, ‘corrected’ or ‘unfound’. However, this proved inadequate for addressing the complexities of the data, as we will discuss, with examples. Our solution was to initially treat the retrieved hospital notes as simply another source of follow-up data. We were thus able to use our existing systems for validating, standardising and aggregating events; and thus produce validated endpoints that were meaningfully comparable to our reported endpoints. We could then implement and test definitions of the required validation statuses at a participant level for each disease of interest. Conclusion/ImplicationsThis validation project was a huge and daunting undertaking, but repaid our investment with proof that our Electronic Health Records were generally very reliable, and also with much richer data about disease diagnosis and phenotyping. Other projects using Electronic Health Records may wish to adopt this approach.


PLoS ONE ◽  
2016 ◽  
Vol 11 (5) ◽  
pp. e0154515 ◽  
Author(s):  
Shang-Ming Zhou ◽  
Fabiola Fernandez-Gutierrez ◽  
Jonathan Kennedy ◽  
Roxanne Cooksey ◽  
Mark Atkinson ◽  
...  

PLoS ONE ◽  
2021 ◽  
Vol 16 (7) ◽  
pp. e0254661
Author(s):  
Alex M. Trafford ◽  
Rosa Parisi ◽  
Martin K. Rutter ◽  
Evangelos Kontopantelis ◽  
Christopher E. M. Griffiths ◽  
...  

Background The association between psoriasis and the risk of cancer has been investigated in numerous studies utilising electronic health records (EHRs), with conflicting results in the extent of the association. Objectives To assess concordance and timing of cancer recording between primary care, hospital and death registration data for people with and without psoriasis. Methods Cohort studies delineated using primary care EHRs from the Clinical Practice Research Datalink (CPRD) GOLD and Aurum databases, with linkage to hospital episode statistics (HES), Office for National Statistics (ONS) mortality data and indices of multiple deprivation (IMD). People with psoriasis were matched to those without psoriasis by age, sex and general practice. Cancer recording between databases was investigated by proportion concordant, that being the presence of cancer record in both source and comparator datasets. Delay in recording cancer diagnoses between CPRD and HES records and predictors of discordance were also assessed. Results 58,904 people with psoriasis and 350,592 comparison patients were included using CPRD GOLD; whereas 213,400 people with psoriasis and 1,268,998 comparison patients were included in CPRD Aurum. For all cancer records (excluding keratinocyte), concordance between CPRD and HES was greater than 80%. Concordance for same-site cancer records was markedly lower (<68% GOLD-linked data; <72% Aurum-linked data). Concordance of non-Hodgkin lymphoma and liver cancer recording between CPRD and HES was lower for people with psoriasis compared to those without. Conclusions Concordance between CPRD and HES is poor when restricted to cancers of the same site, with greater discordance in people with psoriasis for some cancers of specific sites. The use of linked patient-level data is an important step in reducing misclassification of cancer outcomes in epidemiological studies using routinely collected electronic health records.


Sign in / Sign up

Export Citation Format

Share Document